ad5-ebov
Vaccineexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2014 (NCT02326194)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- EbolavirusImmunity, active
Ebolavirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ad5-ebov
- ad5-ebov0
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02533791 | Phase 1 | Jul 1, 2015 | Beijing Institute of Biotechnology, Government of China, Tianjin Cansino Biotechnology Inc |
| NCT02401373 | Phase 1 | Mar 1, 2015 | People's Liberation Army of China, Tianjin Cansino Biotechnology Inc, Zhejiang University |
| NCT02326194 | Phase 1 | Dec 1, 2014 | Beijing Institute of Biotechnology, Government of China, Tianjin Cansino Biotechnology Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Tianjin Cansino Biotechnology Inc | For profit | 3 | 0 | 1 | 2014 |
| Beijing Institute of Biotechnology | Academic/Hospital | 2 | 0 | 1 | 2014 |
| Government of China | Government | 2 | 2 | 1 | 2014 |
| People's Liberation Army of China | Government | 1 | 0 | 1 | 2015 |
| Zhejiang University | Academic/Hospital | 1 | 1 | 1 | 2015 |
5 organizations
Page 1 / 1